Expo Focuses on Caregiver Needs

Published Online: Tuesday, March 1, 2005

The Family Caregiver Expo is the first caregiver exposition created to meet the needs of those who take care of a family member or other loved ones, as well as underscoring the importance of family health and well-being. It is estimated that more than 50 million people a year provide care for a chronically ill, disabled, or aged family member or friend. Oftentimes, a majority of the caregivers underestimate the period of time they will be caring for their family members, according to the National Family Caregiver Association.

During the expo, there will be demonstrations and health screenings for attendees to learn how to be helpful caregivers. Attendees also will receive information on caregiver support groups, as well as new developments in the caregiver field.

"There is an immediate and critical need to provide education and forums for the senior population and the people who care for them,"said Craig Fuller, president and chief executive officer of the National Association of Chain Drug Stores. The association was one of the expo creators. "With the creation of this first-ever caregiver expo, attendees will have the chance to speak with legal counsel, hospice care, nursing homes, pharmacists, and additional health care advisors about their specific family or health care needs,"Fuller said.

The Family Caregiver Expo will be held May 13-14, 2005, at the Washington Convention Center in Washington, DC. The event is free for attendees.

Latest Articles
Propranolol is red, digoxin is blue. Your pharmacist’s heart may skip a beat if they get a valentine from you.
Health-system pharmacists can play a critical role in managing drug shortages to prevent medical errors and adverse events.
The White House is asking Congress for more than $1.8 billion in emergency funding to combat the Zika virus, which is creeping into the United States and ravaging some foreign countries.
Vertex Pharmaceuticals has received a complete response letter from the FDA for its supplemental new drug application for ivacaftor.
Latest Issues